郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Combination of FACS and homologous recombination for the generation of stable and high-expression engineered cell lines.

期刊：PloS one发表年份：2014作者：Lei Shi; Xuesi Chen; Wenying Tang; Zhenyi Li; Jin Liu; Feng Gao; Jianli Sang
阅读更多 →

药效评价Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.

期刊：European journal of medicinal chemistry发表年份：2014作者：Bassem Sadek; Johannes Stephan Schwed; Dhanasekaran Subramanian; Lilia Weizel; Miriam Walter; Abdu Adem; Holger Stark
阅读更多 →

药效评价Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325.

期刊：British journal of pharmacology发表年份：2014作者：M Iijima; T Yoshimizu; T Shimazaki; K Tokugawa; K Fukumoto; S Kurosu; T Kuwada; Y Sekiguchi; S Chaki
阅读更多 →

药效评价Agonists for the adenosine A1 receptor with tunable residence time. A Case for nonribose 4-amino-6-aryl-5-cyano-2-thiopyrimidines.

期刊：Journal of medicinal chemistry发表年份：2014作者：Julien Louvel; Dong Guo; Marta Agliardi; Tamara A M Mocking; Roland Kars; Tan Phát Pham; Lizi Xia; Henk de Vries; Johannes Brussee; Laura H Heitman; Adriaan P Ijzerman
阅读更多 →